A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
|Effective start/end date||4/1/23 → 4/1/24|
- TREKKA THERAPEUTICS, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.